pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
Tartisan Nickel Corp. Acquires Nickel-Copper Claims, Outlines 2026 Work Program at Turtle Pond, Northwestern Ontario
Charbone Annonce Les Resultats De L'assemblee Generale Annuelle Et Extraordinaire Des Actionnaires Et L'octroi D'attributions D'actions
Charbone Announces Annual General and Extraordinary Meeting of Shareholders' Results and Grants Equity Awards
